Background {#Sec1}
==========

The inclusion of PLN metastatic status into the recently revised International Federation of Gynaecology and Oncology (FIGO) staging system has shown to be prognostic on historical cohort, hence may better identify patients for radiation dose escalation to suspicious PLNs to improve locoregional control and survival \[[@CR1]--[@CR4]\]. In cervical cancer, MRI is used to evaluate the primary tumour extent and at the same time to assess lymph node involvement, in which the diagnosis of the latter relies on size- and morphology-based criteria on T2-weighted (T2W) images \[[@CR5]--[@CR7]\]. However, these criteria have shortcomings in that they are susceptible to false positives due inflammatory enlarged lymph nodes \[[@CR8], [@CR9]\] and false negatives due to difficulties in detecting sub-centimetre metastatic PLNs \[[@CR10]\]. Ultimately, these criteria have resulted in low pooled sensitivity of 53--56% despite high specificity of 91--93% \[[@CR11], [@CR12]\].

Pathological assessment of resected lymph nodes provides definitive diagnosis; however, pelvic lymph node dissection (PLND) is not routinely performed in early bulky and locally advanced cervical cancer (LACC) treated by concurrent chemoradiation (CCRT) \[[@CR13]\]. FDG-PET/CT, which has been shown to have high accuracy \[[@CR11]\] in identifying PLN involvement, is used clinically to determine the nodal status but imparts substantial radiation burden with its high cost and limited availability. Therefore, it can be useful in identifying non-invasive imaging features of the primary tumour on MRI that are associated with the presence of PLN metastases in cervical cancer.

There has been interest in the use of diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) to characterize the primary tumour in cervical cancer, and ADC has been shown to be associated with various clinicopathological factors such as FIGO stage, histological grade, including nodal status \[[@CR14]--[@CR16]\]. Previous studies have demonstrated the utility of ADC to distinguish between benign and malignant mediastinal masses as well as axillary lymph nodes in patients with breast cancer \[[@CR17], [@CR18]\]. However, the diffusional signal in cervical cancer is thought to be better ascribed to the intravoxel incoherent motion (IVIM) biexponential model and the perfusion effects are non-negligible \[[@CR19]--[@CR21]\]. There is growing interest in applying advanced diffusion models, such as IVIM, diffusion kurtosis imaging (DKI), and diffusion tensor imaging (DTI) to discriminate between malignant and benign masses as well as characterize tumours \[[@CR22]--[@CR24]\]. Specifically in the female pelvis, previous studies have demonstrated the feasibility of IVIM and suggested that this technique could be used to aid in the clinical management of LACC patients \[[@CR20], [@CR25], [@CR26]\].

The purpose of this study was to assess the classification performances of IVIM parameters of the primary cervical tumour in classifying PLN involvement, particularly in the detection of sub-centimetre lymph node metastasis, and to compare them with lymph node staging performance of radiologists via visual assessment.

Methods {#Sec2}
=======

Patients {#Sec3}
--------

This retrospective study was approved by and done in accordance with the regulations set by the local Institutional Review Board. This study involved anonymized human data without identifying information that has already been collected waiving the need for informed consent. Patients were retrospectively recruited from March 2012 to January 2018. Inclusion criteria were: histologically confirmed squamous cell carcinoma (SCC) or adenocarcinoma LACC; FIGO stage of IB2 or higher; treatment-naïve; and who underwent either additional pre-operative FDG-PET/CT staging or subsequent PLND. A total of 50 consecutive patients were thus identified.

MRI {#Sec4}
---

Patients were asked to fast at least 6 h before the examination and 20 mg hyoscine butylbromide (Buscopan, Boehringer Ingelheim, Germany) was given intramuscularly at the beginning of each examination to reduce bowel peristalsis. Images were acquired with a 3 T MRI system (Achieva 3.0 T TX, Philips Healthcare, Best, the Netherlands) using a dedicated 16-channel phased array torso coil. All patients were imaged on the same scanner. The conventional sequences are tabulated on Table [1](#Tab1){ref-type="table"}. DWI utilized single-shot spin-echo echo-planar imaging, which was acquired immediately after the axial T2W imaging. It was performed in free breathing with background body signal suppression (pre-saturation inversion recovery fat suppression) with parallel imaging and sensitivity encoding (SENSE) factor of 2. Thirteen *b*-values (0, 10, 20, 30, 40, 50, 75, 100, 150, 300, 500, 800, and 1000 s/mm^2^) in the axial plane encompassing 20 slices to include the entire primary tumour motion-probing gradients in three orthogonal axes. Table 1Summary of MRI scan parameters. CE: contrast-enhanced, DWI: diffusion-weighted imaging; FFE: fast field echo; TR/TE: repetition time/echo; TSE: turbo spin echo; SPAIR: Spectral Attenuation Inversion Recovery; SENSE: sensitivity encodingSequencesT2W TSET2W SPAIRT2W TSEDWICE 3D T1W FFEPlaneSagittalCoronalAxialAxial3DTR/TE (ms)4000/803500/802800/1002000/543/1.4Turbo factor302112NANASENSE factor22222Field of view (mm)240 × 240230 × 230402 × 300406 × 300370 × 203Matrix size480 × 298352 × 300787 × 600168 × 124248 × 134Slice thickness (mm)44441.5Intersection gap (mm)00000Bandwidth (Hz/pixel)23018616915.3724Number of excitations21121

Image analysis {#Sec5}
--------------

Two board-certified radiologists, one subspecialist in gynae-oncological imaging (\> 10 years of experience in female pelvic imaging and cross-sectional imaging) and one non-subspecialist (\> 10 years of experience in cross-sectional imaging), staged patients' PLN status by visually examining for PLN involvement using the size, morphology and signal-based criteria on T2W images and DWI \[[@CR5]--[@CR7]\]. In short, PLNs with short axis larger than 1 cm on T2W-MRI, round morphology and/or containing signal similar to the primary tumour was considered malignant. PLN involvement was then confirmed using FDG-avidity from pre-operative staging FDG-PET/CT or subsequent histological findings from PLND (Figs. [1](#Fig1){ref-type="fig"} and [2](#Fig2){ref-type="fig"}). Any FDG uptake more than the background liver activity along the pelvic nodal chain was considered positive \[[@CR27]\]. Fig. 1A case of a 69-year-old patient International Federation of Gynaecology and Obstetrics (FIGO) staged IIA with a sub-centimetre pelvic lymph nodes on parametric maps of (**a**) axial fused ^18^F-fluoro-deoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) image and (**b**) axial T2-weighted (T2W) image. This patient was classified as metastatic by the IVIM models and correctly staged by the subspecialist but not the non-subspecialist.Fig. 2A case of a 67-year-old patient International Federation of Gynaecology and Obstetrics (FIGO) staged IIIB with a sub-centimetre pelvic lymph node on parametric maps of (**a**) coronal fused ^18^F-fluoro-deoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) image and (**b**) axial T2-weighted image. This patient was classified as metastatic by the IVIM models and correctly staged by the subspecialist but not the non-subspecialist.

Volumes of interest (VOIs) were manually drawn by both radiologists to encompass the entirety of primary tumours on the *b*1000 images with reference to co-registered T2W images and ADC maps. Areas of hyperintensity on the *b*1000 maps were taken as the primary tumour and radiologists segmented the tumour with reference to co-registered T2W images and ADC maps. These VOIs were then copied to co-registered parametric maps. IVIM maps were visually inspected and VOIs were adjusted if needed (Fig. [3](#Fig3){ref-type="fig"}). Fig. 3Representative example of the placement of region of interest in the parametric maps of (**a**) T2-weighted image, (**b**) apparent diffusion coefficient (ADC), (**c**) pure diffusion coefficient (D), and (**d**) perfusion fraction (*f*) on a case of a 66-year old patient International Federation of Gynaecology and Obstetrics (FIGO) staged IIA2. This was repeated on subsequent slices to include the entire tumour volume.

DWI analysis {#Sec6}
------------

The monoexponential model of DWI was based on the geometric averaged DWI signal from three orthogonal axes. ADC map was calculated with 2 *b*-values (0, 1000 s/mm^2^) using the function: $$\documentclass[12pt]{minimal}
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                \begin{document}$$ \frac{S_b}{S_0}=\exp \left(-b\bullet \mathrm{ADC}\right) $$\end{document}$$where S~b~ represents the mean signal intensity with the diffusion gradient, *b*, S~0~ is the mean signal intensity when *b* = 0 s/mm^2^. Diffusion tumour volume (DTV) was calculated by multiplying the tumour areas on *b*1000 images by the slice thickness.

The biexponential model, IVIM, was analysed using all 13 *b*-values acquired and parametric maps of D, *f*, and pseudo-diffusion coefficient (D\*) were generated using the biexponential model described by the function: $$\documentclass[12pt]{minimal}
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A 3 × 3 gaussian smoothing filter was first applied for pre-processing before fitting using non-linear least squares with non-negative constraints under a Levenberg-Marquardt routine by an in-house algorithm in MATLAB (The MathWorks Inc., Natick, MA, USA). The two-step approach was implemented by estimating D first, then followed by *f* and D\*. Incorrectly fitted pixels with pixel values of ADC and D \> 3 × 10^− 3^ mm^2^/s, and *f* \> 1 were excluded from analysis \[[@CR28], [@CR29]\]. Mean values of the parameters ADC, D, and *f* were then calculated and considered for subsequent analysis. D\* was excluded from further analysis due to low signal-to-noise ratio \[[@CR28], [@CR30]\].

Statistical analysis {#Sec7}
--------------------

All statistical analyses were executed in R version 3.2.3 (R Development Core Team).

### Primary tumour associations with nodal status {#Sec8}

The cohort was stratified into three groups: patients with no nodal involvement, patients with nodal involvement but whose largest PLN had a short axis of less than 1 cm on T2W images (sub-centimetre involvement), and patients with at least one PLN larger than 1 cm (size-significant involvement). Kruskal-Wallis tests were then used to test for ADC and IVIM parameter differences between the nodal involvement groups and Nemenyi tests for pairwise comparisons between groups.

The Fisher's exact test was used to test for associations between PLN involvement with histological sub-type and with FIGO stage.

### Interobserver and intraobserver reproducibility {#Sec9}

Intraclass Correlation Coefficient (ICC) analysis was used to assess interobserver variability of ADC and IVIM parameters quantified from the VOIs of both radiologists. ICC measures agreement and ranges from 0 to 1, where values between 0.50--0.75 are considered moderate, 0.76--0.90 are considered good, and above 0.90 are considered excellent agreement \[[@CR31]\].

### Classification models of PLN staging {#Sec10}

A logistic regression model based on IVIM histogram features derived from the VOIs of the subspecialist was developed to classify PLN involvement (regardless of PLN size) where up to 2 features were selected \[[@CR32]\]. Feature selection was executed using stepwise forward regression. To test for the effect of interobserver variation in manual segmentation, the developed model was fitted on features derived from the VOIs of the non-subspecialist.

Model performance were compared to the performances of the radiologists' nodal staging. The models were assessed using receiver operating characteristic (ROC) analysis. Relative performance of the models was assessed by computing the Z-statistic of the accuracy confidence intervals of each model's accuracy, i.e. the degree of CI overlap between of two models' accuracies, using the IVIM classification model based on the VOIs of the subspecialist as reference \[[@CR33]\].

Results {#Sec11}
=======

Clinicopathological characteristics {#Sec12}
-----------------------------------

The median age of patients was 54 (28--78) years old. Thirty-five patients were of the SCC sub-type and the remaining 15 were of the adenocarcinoma sub-type. Eighteen patients were FIGO stage IB, 5 were FIGO stage IIA, 10 were stage IIB, 2 were FIGO stage IIIA, 14 were FIGO stage IIIB, and 1 was FIGO stage IVB. There was an average of 12.8 days between the MRI scan and FDG-PET/CT or PLND. Pelvic lymph node assessment by FDG-PET/CT was done in 41 patients, while 9 patients had PLND. Twenty patients were found to have PLN involvement by FDG-PET/CT assessment. One PLND candidate was found to have PLN involvement. Of the 21 patients with PLN involvement, 10 had sub-centimetre involvement. The mean DTV was 37.68 (0.95--193.58) cm^3^. There were no associations between PLN involvement with histological sub-type (*p =* 0.074) and FIGO staging (*p* = 0.254).

Tumour characteristics {#Sec13}
----------------------

DTV increased while ADC, D, and *f* decreased as the nodal status progressed from no malignant involvement to sub-centimetre and then size-significant PLN involvement, though the differences in D among the different groups were not significant (Table [2](#Tab2){ref-type="table"} and Fig. [4](#Fig4){ref-type="fig"}). Pairwise group comparisons may be found on Fig. [4](#Fig4){ref-type="fig"}. Interobserver variability of ADC, D, and *f*, were excellent (ICC = 0.961, 0.947, and 0.943 respectively). Table 2Apparent diffusion coefficient (ADC) and intravoxel incoherent motion (IVIM) parameter values of the primary tumour between patients without nodal involvement, those with sub-centimetre involvement, and those with size-significant involvement. ADC: apparent diffusion coefficient (x 10^− 3^ mm^2^/s); D: pure diffusion coefficient (x 10^− 3^ mm^2^/s); *f*: perfusion fraction. PLN: pelvic lymph nodeNo involvementSub-centimetre involvementSize-significant involvement***p***-valueDTV (cm^3^)22.84 ± 22.8454.04 ± 52.4250.18 ± 34.630.013ADC (10^−3^ mm^2^/s)1.07 ± 0.150.98 ± 0.140.93 ± 0.110.015D (10^− 3^ mm^2^/s)0.91 ± 0.160.84 ± 0.120.80 ± 0.090.057*f*0.19 ± 0.040.15 ± 0.030.16 ± 0.040.006Fig. 4Boxplots of the diffusion tumour volume (DTV), perfusion fraction (*f*), apparent diffusion coefficient (ADC), and pure diffusion coefficient (D) measurements of the primary tumour separated by nodal involvement with pairwise group comparisons.

PLN staging {#Sec14}
-----------

Tabulated diagnostic performances of radiologists may be found in Table [3](#Tab3){ref-type="table"}. The optimal IVIM classification model consisted of DTV and *f*. Classification accuracy of the IVIM classification model to determine PLN involvement regardless of size was similar to the diagnostic accuracies of subspecialist and non-subspecialist (Table [3](#Tab3){ref-type="table"}). However, the IVIM model correctly identified 9 of the 10 patients with sub-centimetre PLN involvement, which gave it the same performance as the subspecialist (*p* = 1.00) but better performance that the non-subspecialist (*p* = 0.01) (Table [4](#Tab4){ref-type="table"}). The performance of the classification model was not susceptible to interobserver variation in the manual segmentation of the primary tumour. Table 3Pelvic lymph node involvement classification performances of the radiologists as well as the classification performances of the intravoxel incoherent motion (IVIM) classification models. The *p*-values of the relative classification performances of each model are given where the first IVIM classification model served as the reference. The first IVIM model used parameters dervied from the subspecialist's tumours segmentations, and the second IVIM model used parameters dervied from the non-subspecialist's tumour segementations. VOI: Volume of InterestAccuracySensitivitySpecificity***p-value*Radiologists**Subspecialist0.900.950.860.31Non-subspecialist0.760.620.860.73**Model**Subspecialist VOI0.800.710.86refNon-subspecialist VOI0.820.800.820.86Table 4Patients with sub-centimetre metastatic pelvic lymph node (PLN) involvement and the nodal staging given by the radiologists as well as the PLN classification given by the intravoxel incoherent motion (IVIM) models. Correct staging or classification of PLN involvement despite size-insignificance are marked with the character 'X'CodeSubspecialistNon-subspecialistIVIM Model (Subspecialist)IVIM Model (Non-subspecialist)1XXX13XXX17XXX21XXX23XXX28XXX30XXXX32X38XXXX44XXX

Discussion {#Sec15}
==========

In this current study, we demonstrated that DTV increased while ADC, D, and *f* decreased in the primary tumour as the nodal status progressed from no malignant involvement to sub-centimetre and then size-significant PLN metastases. The accuracy of the IVIM classification model was comparable to radiologists in classifying PLN involvement regardless of size but it had higher accuracy compared to the non-subspecialist in the detection of sub-centimetre metastatic PLNs.

The decreasing trend in ADC observed in this study suggests that more invasive tumours are characterized by increased cellularity. This was in corroboration with the previous study by *Schob* et al. which found that node-positive tumours had significantly lower ADC compared to node-negative tumours \[[@CR34]\], though a study by *Xue* et al. found no difference in ADC values between the two groups \[[@CR35]\]. The discrepancy may be due to the differences in DWI acquisition, in which the former had a similar acquisition to the present study (3 T MRI with b-values 0 and 1000 s/mm^2^), while the latter used a lower field strength and different b-value combination (1.5 T MRI with b-values 0 and 800 s/mm^2^).

We also observed a decreasing trend in D, though this trend was not significant, which suggests that there are some non-negligible perfusion effects. Immunohistochemical studies have suggested that acute hypoxia from reduced tumour perfusion increased the tumour's metastatic capacity \[[@CR36], [@CR37]\]. Similarly, dynamic contrast-enhanced (DCE) MRI studies have shown that poor perfusion was associated with an increase in the nodal metastatic capacity of the primary tumour \[[@CR37], [@CR38]\], which could be related to the poor tumour oxygenation \[[@CR39], [@CR40]\]. While it is believed that the two techniques do not measure the same perfusion phenomenon \[[@CR41], [@CR42]\], the study by *Lee* et al. found significant correlations between IVIM perfusion and DCE perfusion in cervical cancer \[[@CR43]\]. Moreover, a previous study found that dynamic susceptibility contrast (DSC) percentages were lower in malignant cervical nodes compared to benign nodes which indicate restricted microcapillary perfusion \[[@CR44]\]. This may explain why the perfusivity characteristics, rather than microarchitecture of the primary tumour, adds value in classifying the metastatic propensity in cervical cancer.

It has been shown that at least part of a PLNs has similar microarchitecture to the primary tumour \[[@CR45]\]. We observed significant differences in ADC and *f* values of the primary tumour between PLN involvement groups, but not in D percentiles. Our observation partially concurred with the study by *Wu* et al. that found that metastatic LNs had lower *f* values; however, they found that PLNs had higher D values \[[@CR46]\]. In that study, lymph nodes with small volumes were included in analysis and might affect quantification of diffusion parameters due to partial volume effects \[[@CR47]\], potentially accounting for the discrepant result observed in our study. On the other hand, the observed ADC results concur with the other studies that attributed lower ADC in metastatic lymph nodes to tumour tissue invasion, leading to increased cellularity and enlarged cell size \[[@CR48]--[@CR50]\].

The IVIM classification model suggests that PLN involvement is best characterised by the tumour's diffusion volume and perfusivity and its overall accuracy was similar to that of radiologists. When identifying patients with sub-centimetre PLN involvement, the subspecialist performed better than the non-subspecialist, likely related to the greater experience and more emphasis placed on the morphology and signal of the PLN over the size criterion. The IVIM classification model had similar accuracy as the subspecialist's staging in identifying patients with sub-centimetre metastatic PLNs. As we did not observe any significant differences in any parameters examined between tumours with sub-centimetre involvement and those with size significant involvement, it is likely that these tumours have similar diffusion and perfusion characteristics. This suggests that parametric IVIM could serve as adjunct tool for a non-subspecialist and provide an objective quantification when staging lymph node involvement.

This study has several limitations. First, this was a retrospective, single-centre study with a relatively small sample size. Second, extended scan coverage and the direct measurements of the diffusional signals of PLNs and were not performed due to the inherently longer scan time with IVIM. Though not clinically routine, previous studies have explored use of quantitative DWI to detect lymph node metastasis, which was shown to have a pooled sensitivity of 86--87% and specificity of 83--84% \[[@CR12], [@CR51]\]. Third, while the existence hyperplastic lymph nodes has been noted as a major source of false positives in MRI PLN assessment, we could not analyse hyperplastic lymph nodes due to the low number of false positives in our radiologists' classifications. Lastly, only a small proportion of our patients (*n =* 9) had histological confirmation of the nodal status and majority (*n =* 41) had their nodal status determined by FDG-PET/CT. FDG-PET/CT is supported by the latest FIGO staging guidelines in nodal assessment given its high sensitivity of 83%, especially in PLN staging and low false negative rate of 4--15% in LACC \[[@CR12], [@CR52], [@CR53]\].

Conclusions {#Sec16}
===========

IVIM analysis of the primary tumour in cervical cancer is potentially useful in determining PLN involvement and could provide more objective and quantifiable evaluation, but its added value is diminished as reader experience increases in the detection of sub-centimetre PLNs.
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